Relationship between the dimension of parathyroid glands estimated by ultrasonography and the hyperplastic pattern in patients with renal hyperparathyroidism

Therapeutic Apheresis and Dialysis

Volumn 12, Issue 5, 2008, Pages 391-395

  Matsuoka, Susumu ^a   Tominaga, Yoshihiro ^a   Sato, Tetsuhiko ^a   Uno, Nobuaki ^a   Hiramitu, Takahisa ^a   Goto, Norihiko ^a   Nagasaka, Takaharu ^a   Uchida, Kazuharu ^a  

^a NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

Author keywords

Hyperplastic pattern; Parathyroid gland size; Parathyroidectomy; Renal hyperparathyroidism; Ultrasonography

Indexed keywords

ADULT; ARTICLE; AUTOGRAFT; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NODULAR HYPERPLASIA; PARATHYROID GLAND; PARATHYROID HYPERPLASIA; PARATHYROIDECTOMY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RENAL OSTEODYSTROPHY; SENSITIVITY AND SPECIFICITY;

ADULT; COHORT STUDIES; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; ORGAN SIZE; PARATHYROID GLANDS; PARATHYROID HORMONE; PARATHYROIDECTOMY; PROBABILITY; PROGNOSIS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER;

EID: 53749085342     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2008.00615.x     Document Type: Article

References (23)

1. Gogusev J, Duchambon P, Hory B et al. Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int 1997 51 : 328 36.
2. Fukuda N, Tanaka H, Tominaga Y, Fukagawa M, Kurokawa K, Seino Y. Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 1993 92 : 1436 43.
3. Albright F, Baird PC, Cope O, Bloomberg E. Studies on the physiology of parathyroid glands. IV. Renal complications of hyperparathyroidism. Am J Med Sci 1934 187 : 49 65.
4. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004 15 : 2208 18.
5. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998 31 : 601 17.
6. Tominaga Y, Johansson H, Johansson H, Takagi H. Secondary hyperparathyroidism: pathophysiology, histopathology, and medical and surgical management. Surg Today 1997 27 : 787 92.
7. Tominaga Y, Kohara S, Namii Y et al. Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism. World J Surg 1996 20 : 744 50.
8. Tominaga Y, Tanaka Y, Sato K, Nagasaka T, Takagi H. Histopathology, pathophysiology and indications for surgical treatment of renal hyperparathyroidism. Semin Surg Oncol 1997 13 : 78 86.
9. Tominaga Y. Management of renal hyperparathyroidism. Biomed Pharmacother 2000 54 : 25s 31s.
10. Tominaga Y. Surgical management of secondary hyperparathyroidism in uremia. Am J Med Sci 1999 317 : 390 7.
11. Matsuoka S, Tominaga Y, Uno N et al. Surgical significance of undescended parathyroid gland in renal hyperparathyroidism. Surgery 2006 139 : 815 20.
12. Tominaga Y, Matsuoka S, Sato T. Surgical indications and procedures of parathyroidectomy in patients with chronic kidney disease. Ther Apher Dial 2005 9 : 44 7.
13. Matsuoka S, Tominaga Y, Sato T et al. Recurrent renal hyperparathyroidism caused by parathyromatosis. World J Surg 2007 31 : 299 305.
14. Matsuoka S, Tominaga Y, Sato T et al. Intraoperative Quick Bio-intact PTH Assay at Parathyroidectomy for Secondary Hyperparathyroidism. World J Surg 2007 31 : 824 31.
15. Tominaga Y, Sato K, Tanaka Y, Numano M, Uchida K, Takagi H. Histopathology and pathophysiology of secondary hyperparathyroidism due to chronic renal failure. Clin Nephrol 1995 44 : S42 S47.
16. Tominaga Y, Matsuoka S, Sato T et al. Clinical Features and Hyperplastic Patterns of Parathyroid Glands in Hemodialysis Patients With Advanced Secondary Hyperparathyroidism Refractory to Maxacalcitol Treatment and Required Parathyroidectomy. Ther Apher Dial 2007 11 : 266 73.
17. Tominaga Y, Numano M, Uchida K et al. Parathyroidectomy for patients with renal hyperparathyroidism refractory to calcitriol pulse therapy. J Bone Miner Metab 1994 12 : S99 S104.
18. Fukagawa M, Kitaoka M, Yi H et al. Serial evaluation of parathyroid size by ultrasonography is another useful marker for long-term prognosis of calcitriol pulse therapy in chronic dialysis patients. Nephron 1994 68 : 221 8.
19. Douthat WG, Orozco SE, de Arteaga J, Massari PU. Treatment of refractory secondary hyperparathyroidism with ethanol injection: the importance of glandular volume. Kidney Int 2003 63 : S101 4.
20. Katoh N, Nakayama M, Shigematsu T et al. Presence of sonographically detectable parathyroid glands can predict resistance to oral pulsed-dose calcitriol treatment of secondary hyperparathyroidism. Am J Kidney Dis 2000 35 : 465 8.
21. Okuno S, Ishimure E, Kitatani K et al. Relationship between parathyroid gland size and responsiveness to maxacalcitol therapy in patients with secondary hyperparathyroidism. Nephrol Dial Transplant 2003 18 : 2613 21.
22. Tominaga Y, Inaguma D, Matsuoka S et al. Is the Volume of the parathyroid gland a predictor of Maxacalcitol response in advanced secondary hyperparathyroidism? Ther Apher Dial 2006 10 : 198 204.
23. Onoda N, Kurihara S, Sakurai Y et al. Evaluation of blood supply to the parathyroid glands in secondary hyperparathyroidism compared with histopathology. Nephrol Dial Transplant 2003 18 : 34 7.